Patient engagement and attrition in pediatric obesity clinics and programs: results and recommendations

Sarah Hampl1, Heather Paves, Katie Laubscher

  • 1Weight Management and General Pediatrics, Children's Mercy Hospital, 2401 Gillham Rd, Kansas City, MO 64108, USA. shampl@cmh.edu

Pediatrics
|September 3, 2011
PubMed

Insights

Pediatric weight management programs struggle with high patient dropout rates. Understanding and implementing effective retention strategies is crucial for improving treatment success in childhood obesity interventions.

Area of Science:

  • Pediatric Endocrinology
  • Obesity Medicine
  • Healthcare Management

Background:

  • Pediatric tertiary care centers offer intensive, multidisciplinary stage 3 treatment for pediatric obesity.
  • High patient attrition rates present a significant challenge to the effective delivery of these interventions.
  • Limited knowledge exists regarding specific practices employed by pediatric weight management clinics to minimize attrition.

Purpose of the Study:

  • To survey pediatric weight management clinics and group-based programs on their methods for engaging and retaining obese children.
  • To benchmark patient nonattendance rates at initial and follow-up visits among participating hospitals.
  • To identify barriers to retention and contrast clinic-based versus group-based program results.

Main Methods:

  • Survey of hospital members and non-members of FOCUS on a Fitter Future regarding patient engagement and retention techniques.
  • Benchmarking activity focused on patient nonattendance rates at clinic visits.
  • Comparative analysis of results from clinic-based and group-based programs.

Main Results:

  • Group-based programs reported that most patients did not complete 50% of follow-up visits.
  • Multiple patient/family-level barriers to retention were identified.
  • Multiple clinic/program-level barriers to retention were identified.

Conclusions:

  • Significant challenges exist in retaining pediatric patients in intensive weight management programs.
  • Both patient/family factors and program-specific elements contribute to attrition.
  • Successful retention techniques should inform the planning and improvement of pediatric obesity interventions.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...